Future perspectives from lung cancer pre-clinical models: new treatments are coming?

Lung cancer currently stands out as both the most common and the most lethal type of cancer, the latter feature being partly explained by the fact that the majority of lung cancer patients already display advanced disease at the time of diagnosis. In recent years, the development of specific tyrosin...

Descripción completa

Detalles Bibliográficos
Autores principales: Bersani, Francesca, Morena, Deborah, Picca, Francesca, Morotti, Alessandro, Tabbò, Fabrizio, Bironzo, Paolo, Righi, Luisella, Taulli, Riccardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article on Looking for Chimeras in NSCLC: Widen Therapeutic Options Targeting Oncogenic Fusions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815341/
https://www.ncbi.nlm.nih.gov/pubmed/33489823
http://dx.doi.org/10.21037/tlcr-20-189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815341/
https://www.ncbi.nlm.nih.gov/pubmed/33489823
http://dx.doi.org/10.21037/tlcr-20-189

Ejemplares similares